Images
The Heraldo newspaper has published an article about the role of immunotherapy to rearm patients’ defences and contribute to the fight against cancer. In the article, the authors mention the work of Eduard Batlle, ICREA researcher at IRB Barcelona and a CIBERONC member, on the effectiveness that enhances immune system function in colon cancer.
Link to Heraldo
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
